Confounding Factors (Epidemiology)
"Confounding Factors (Epidemiology)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Factors that can cause or prevent the outcome of interest but are not intermediate variables of the factor(s) under investigation.
| Descriptor ID |
D015986
|
| MeSH Number(s) |
N05.715.350.240 N06.850.490.718
|
| Concept/Terms |
Confounding Factors (Epidemiology)- Confounding Factors (Epidemiology)
- Confounding Factor (Epidemiology)
- Factor, Confounding (Epidemiology)
- Factors, Confounding (Epidemiology)
- Confounding Factor, Epidemiologic
- Confounding Factors, Epidemiologic
- Epidemiologic Confounding Factor
- Epidemiologic Confounding Factors
- Confounding Variables
- Confounding Variable
- Variable, Confounding
- Variables, Confounding
|
Below are MeSH descriptors whose meaning is more general than "Confounding Factors (Epidemiology)".
Below are MeSH descriptors whose meaning is more specific than "Confounding Factors (Epidemiology)".
This graph shows the total number of publications written about "Confounding Factors (Epidemiology)" by people in this website by year, and whether "Confounding Factors (Epidemiology)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 6 | 6 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 3 | 3 |
| 2009 | 1 | 5 | 6 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 4 | 4 |
| 2012 | 1 | 6 | 7 |
| 2013 | 2 | 4 | 6 |
| 2014 | 0 | 4 | 4 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 3 | 4 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Confounding Factors (Epidemiology)" by people in Profiles.
-
Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies. JAMA. 2019 Feb 12; 321(6):602-603.
-
Natural language processing to ascertain two key variables from operative reports in ophthalmology. Pharmacoepidemiol Drug Saf. 2017 Apr; 26(4):378-385.
-
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding. J Natl Cancer Inst. 2016 10; 108(10).
-
Retrospective Cohort Study of Phototherapy and Childhood Cancer in Northern California. Pediatrics. 2016 06; 137(6).
-
Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):798-814.
-
Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):453-61.
-
Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities. Syst Rev. 2015 Nov 05; 4:147.
-
Confounding by alcohol use: benzodiazepines and risk of liver cancer. Br J Clin Pharmacol. 2015 May; 79(5):872-3.
-
High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions. Stat Med. 2015 Feb 28; 34(5):753-81.
-
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.